Abstract
Background
In cancer patients, positron emission tomography/computed tomography (PET/CT) fused images present less variability in target contouring, respect to use only CT images, respectively. However, the gold standard has not yet been clearly established between radiation oncologists with regard to PET images and the methodology of contouring targets with confidence using PET/CT fused images. The aim of this study was to determine whether integrated PET/CT fused images provide advantages in virtual simulation compared with morphological contouring only with CT.
Material and methods
Thirty cancer patients were evaluated in an adapted PET/CT hybrid in radiotherapy (RT) setup position, with 20 of them being suitable for RT: 17 were suitable for curative intent, which was the group of interest in this study. All image series were sent to the RT work station (WS) where CT and PET series were automatically fused by Digital Imaging and Communications in Medicine (DICOM) in each case. PET series were threshold and were subjected to source-to-background contrast algorithms to finally redefine the original tumour description. Three different radiotherapy plans (RTP) for each patient were compared after targets were contoured: [1] planning over metabolic (PET) contoured targets, [2] planning over only morphologic (CT) targets, and [3] planning over targets obtained for treatment based on fused PET/CT images.
Results
PET/CT findings altered initial-stage planning in four patients (23.5%) because they had been undergoing chemotherapy. Gross target volume (GTV) and planning target volume (PTV) based only on PET showed more homogeneity to obtain mean doses (p = 0.025) with respect to those based on PET/CT, respectively. However, no percentage differences were observed in median PTV doses between the planning methods, although there was higher variability in PET/CT planning. Morphological (CT) and PET/ CT target volumes were more voluminous than metabolic (PET) volumes. On the other hand, 20% of metabolic (PET) PTV were out of those defined by PET/CT. Thoracic RT plans based on PET preserved better bilateral lung [percentage volume of lung irradiated with a dose of 20 Gy (V20); significance, R2 = 0.559, p = 0.006].
Conclusions
For our physicians, PET/CT fused images allowed better contouring of primary tumours in 40% of head and neck cancers and 34% of thoracic cancers. PET/CT provides useful information for virtual simulation therapy. Image treatment and planning in an RT workstation is mandatory.
Similar content being viewed by others
References
MacManus M, Leong T (2007) Incorporating PET information into radiation therapy planning. Biomed Imaging Interv J 3(1):e4
MacManus MP, Hicks RJ (2008) Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography. Int J Radiat Oncol Biol Phys 71:2–4
Shintani SA, Foote RL, Lowe VJ et al (2008) Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys 70:322–329
Nestlé U, Kremp S, Schaefer-Schuler A et al (2005) Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 46:1342–1348
Chao KS, Wippold FJ, Ozyigit G et al (2002) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174–1184
Schallenkamp JM, Miller RC, Brinkmann DH et al (2007) Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 67:410–416
Fox JL, Rengan R, O’Meara W et al (2005) Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 62:70–75
Jarritt PH, Carson KJ, Hounsell AR et al (2006) The role of PET/CT scanning in radiotherapy planning. Br J Radiol 79Spec No 1:S27–S35
Senan S, De Ruysscher D (2005) Critical review of PET-CT for radiotherapy planning in lung cancer. Crit Rev Oncol Hematol 56:345–351
Belderbos JS, Kepka L, Spring Kong FM et al (2008) Report from the International Atomic Energy Agency (IAEA) consultants’ meeting on elective nodal irradiation in lung cancer: nonsmall- cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 72:335–342
Schild SE (2008) Elective Nodal Irradiation (ENI) doesn’t appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 72:311–312
Hervas Moron A (2007) PET-CT in oncology. Clin Transl Oncol 9:473–474
Vernon MR, Maheshwari M, Schultz CJ et al (2008) Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 70:678–684
Wang D, Schultz CJ, Jursinic PA et al (2006) Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65:143–151
Faria SL, Menard S, Devic S et al (2008) Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings. Int J Radiat Oncol Biol Phys 70:1035–1038
Nestle U, Kremp S, Grosu AL (2006) Practical integration of [18F]-FDG-PET and PETCT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81:209–225
Nimmagadda S, Ford EC, Wong JW et al (2008) Targeted molecular imaging in oncology: focus on radiation therapy. Semin Radiat Oncol 18:136–148
McManus M, Nestle U, Rosenzweig KE et al (2006–2007) Use of PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiother Oncol 91:85–94
Ashamalla H, Rafla S, Parikh K et al (2005) The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63:1016–1023
Videtic GM, Rice TW, Murthy S et al (2008) Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. Int J Radiat Oncol Biol Phys 72:702–706
Leong T, Everitt C, Yuen K et al (2006) A prospective study to evaluate the impact of FDGPET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78: 254–261
Soto DE, Kessler ML, Piert M et al (2008) Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. Radiother Oncol 89:13–18
Choi JY, Jang HJ, Shim YM et al (2004) 18FFDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 45:1843–1850
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vila, A., Sánchez-Reyes, A., Conill, C. et al. Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning. Clin Transl Oncol 12, 367–373 (2010). https://doi.org/10.1007/s12094-010-0518-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-010-0518-4